ICT enabling persons with disabilities to work from anywhere

admin   •   June 18, 2014   •   9912

Department of Science and Technology (DOST) logo

From the Department of Science and Technology via Official Gazette

Information and Communications Technology (ICT) is now allowing persons with disabilities (PWDs) to become productive members of society, allowing them to work from home without having to commute to work.

Online freelance work is one such ICT innovation that skilled PWDs can use to earn income and become financially independent. It is also consistent with the Philippines reputation of being one of the leading destinations for information and communications technology business process outsourcing.

Online freelance work, officially called “impact sourcing” is a growing trend in the Philippines, with around 100,000 Filipinos now doing online freelance work for various clients. Impact sourcing will be featured extensively in an upcoming ICT Jobs and Skills Fair for PWDs entitled “Work Anywhere Through ICT”. The event is organized by the ICT Office of the Department of Science and Technology (DOST) and the National Council for Disability Affairs (NCDA) in cooperation with various PWD groups, ICT industry associations and SM North Edsa, the official event venue.

According to Ms. Bettina Quimson of the DOST – ICT Office said that; “Persons with disabilities who have difficulty in mobility like our wheelchair users and the blind, to some extent, can already take advantage of the limitless jobs available online”

Other than the usual ICT job fair the event will feature technologies that help PWDs become productive, there will also be testimonials of ICT enabled persons with disabilities who have learned to use ICT to their advantage.

“Work Anywhere Through ICT” will happen on June 19, 2014 at the Cyberzone of SM North Edsa from 11:00 a.m. to 6:00 p.m. Potential participants can register online at:http://icto.dost.gov.ph/index.php/news-events/events/work-anywhere-through-ict

About DOST-ICTO – The Information and Communications Technology Office of the Department of Science and Technology is the Philippine Government’s lead agency on ICT related matters. Its primary thrusts are in the ICT Industry Development, eGovernment, ICT policy development, Internet for all and Cybersecurity.

About NCDA – The National Council on Disability Affairs (NCDA) is the national government agency mandated to formulate policies and coordinate the activities of all agencies, whether public or private, concerning disability issues. As such, the NCDA is the lead agency tasked to steer the course of program development for persons with disabilities and the delivery of services to the sector.

dost.gov.ph

PH gov’t in talks with 6 potential local vaccine manufacturers – DOST

Robie de Guzman   •   April 15, 2021

MANILA, Philippines – The government is currently in talks with six companies that are planning to establish vaccination manufacturing facilities in the Philippines, the Department of Science and Technology (DOST) said Thursday.

In a virtual press briefing, DOST Undersecretary Rowena Cristina Guevara said these companies are local drug makers that have expressed intents to open vaccine-making facilities in the country in the next few years.

“These are local pharmaceutical companies. Wala pa tayong local vaccine manufacturers in the Philippines. These local pharmaceutical companies are trying to come up with a new product, which is a vaccine,” she said.

Guevara declined to name specific companies, citing confidentiality, as negotiations are still ongoing. She, however, gave descriptions of the six firms.

One is a local distributor of a South Korean company, another has extensive facilities in Asia and is planning to partner with a foreign brand name where all the vaccines that the country needs are being manufactured.

The third company is connected to a vaccine developer in Germany, while another firm is planning to start a local vaccine manufacturing business with a fill-and-finish facility.

The fifth company is a long-term partner of a Chinese vaccine producer that is interested in local manufacturing, while the sixth firm is still looking for a possible partner but is planning to partner with a US pharmaceutical company.

Guevara also disclosed that two of these companies have been aggressive in pushing for local vaccine production.

“If they pursue their plans, based on what they have told us, parang kakayanin nilang mag-produce ng vaccine by late 2022,” she said.

Guevara said these manufacturing facilities will not just produce COVID-19 vaccines but also other jabs against rubella, polio, and other vaccine-preventable diseases, for about 40 million doses per year.

The national government has been eyeing to establish the country’s own vaccine institute to locally produce vaccines and sustain the needs for immunization programs.

The DOST said the country is also in talks with 25 international manufacturers, including the Serum Institute of India which has previously offered assistance for the Philippines to locally manufacture vaccines. – RRD (with details from Correspondent Aiko Miguel)

PH vaccine experts mull mixing COVID-19 vaccine brands

Robie de Guzman   •   April 13, 2021

 

MANILA, Philippines – A panel of vaccine experts in the Philippines are studying the possibility of mixing various brands of COVID-19 vaccines amid issues in global vaccine supply, the Department of Science and Technology (DOST) said Tuesday.

Dr. Nina Gloriani, head of the DOST Vaccine Experts Panel (VEP), said they are considering the matter of mixing vaccine brands due to the current scarcity of vaccine supply in the Philippines.

“That is a very practical or realistic scenario that we may be looking at with these so many vaccines that we have now,” she said during a Department of Health (DOH) press briefing.

“Di ba kulang ang ating mga COVID-19 supplies? Sometimes we have to be realistic, ano yung next na pwedeng ibigay? Hindi puwedeng i-delay too long yung second dose,” she added.

Gloriani said these COVID-19 vaccines are not comparable since they are made using different technologies but she noted that some vaccines make use of the same platforms.

“There are some of them na medyo pareho ang platform like Pfizer is messenger RNA, Moderna is messenger RNA,” she said.

“For the adeno(virusDNA approach), iyong mga vector-based vaccines so iyon ang medyo marami, sila Astrazeneca… Dadating na rin ang Gamaleya (Institute) Sputnik V,” she added, referring to the vaccine developed by a Russian company.

Gloriani said a recommendation on the matter will be released soon but she stressed that guidelines for such move should be in place.

The DOH earlier said that there is still no sufficient evidence supporting the benefits of mixing COVID-19 vaccine brands.

The agency also said that it will maintain its position that whatever brand used in the first dose should also be the same brand for the second dose.

DOST, pinag-aaralan ang posibilidad na gumawa ng sariling COVID-19 vaccine ang Pilipinas

Robie de Guzman   •   April 13, 2021

 

MANILA, Philippines – Inaalam na ng Department of Science and Technology (DOST) ang mga hakbang na dapat gawin upang muling makagawa ang Pilipinas ng sarili nitong bakuna.

Ayon kay DOST Vaccine Expert Panel head Dr. Nina Gloriani, kabilang sa kanilang sinisiyasat ay ang kakayahan at kapasidad ng bansa sa pagbuo ng sariling bakuna sa gitna na rin ng kinakaharap na coronavirus pandemic at kakulangan sa supply ng bakuna kontra novel coronavirus disease (COVID-19).

“Pinag-uusapan na hindi tayo pwedeng nasa mercy ng mga iyan na suppliers na kapag ayaw tayong bigyan eh di wala tayo. We have to capacitate, build capacity for the Philippines na sana noon pa nga… Pero we have to learn from all of these,” ani Gloriani.

“Iyong mga iba nakita na nila na hindi lang for COVID but for other vaccines that could be produced here,” dagdag pa niya.

Una nang sinabi ni vaccine czar at National Task Force against COVID-19 chief implementer Secretary Carlito Galvez Jr. na nag-alok ng tulong ang Serum Institute of India para makagawa ng sariling bakuna ang Pilipinas.

Sinabi rin ni Galvez na may kakayahan ang bansa na makagawa ng sariling bakuna laban sa mga sakit gaya ng ginawa noong 1938.

Una nang ring sinabi ni Pangulong Rodrigo Duterte na nais niyang magtayo ng vaccine institute sa bansa bago matapos ang kanyang termino.

Ang Serum Institute of India ay ang sinasabing pinakamalaking vaccine manufacturer sa mundo.

Bukas naman ang Food and Drug Administration (FDA) sa pagtanggap ng tulong mula sa ibang bansa upang muling buhayin ang vaccine production capability ng Pilipinas.

“We used to have a vaccine manufacturing program pero matagal na panahon na iyan. At this time, we don’t.  And during this pandemic it has been, I think, this is one of the realizations. All vaccines kasi talaga in the Philippines are imported at wala tayong self- sufficiency when it comes to vaccines,” ang pahayag ni FDA director-general Eric Domingo.

Hindi naman nawawalan ng pag-asa ang mga eksperto lalo’t malaki ang magagawa ng pagbabakuna upang maproteksyunan ang mga matatanda, bata at mga may sakit mula sa mga malulubhang karamdaman. RRD (mula sa ulat ni Correspondent Aiko Miguel)

REACH US

The Philippine Broadcast Hub

UNTV, 915 Barangay Philam,

EDSA, Quezon City M.M. 1104

(+632) 8396-8688 (Tel)

info@untv-newsandrescue.com (General inquiries)

ABOUT UNTV

UNTV is a major TV broadcast network with 24-hour programming. An Ultra High Frequency station with strong brand content that appeal to everyone, UNTV is one of the most trusted and successful Philippine networks that guarantees wholesome and quality viewing experience.